Erythropoietin doubles the incidence of microvascular obstruction in primary PCI - a randomized controlled trial in acute MI using CMR primary endpoints

Table 1 CMR endpoints day 3 post-PPCI

Endpoint	Placebo	Erythropoietin	P value
LVEF	53 ± 11%	51 ± 7%	P = 0.26
24 hr AUC Trop-T	101.7 ± 67.5 μg/l	114.6 ± 78.3 μg/l	P = 0.56
24 hr AUC CK-MB	3512 ± 2692 μg/l	4682 ± 2946 μg/l	P = 0.15
LGE/AAR	67.8 ± 2.0%	71.5 ± 17.0%	P = 0.58
Myocardial salvage index	0.36 ± 0.23	0.29 ± 0.17	P = 0.28
MVO (incidence)	42%	82%	P = 0.008*
LVEDVi	73 ± 13 ml/m²	84 ± 10 ml/m²	P = 0.003*
LVESVi	34 ± 11 ml/m²	41 ± 9 ml/m²	P = 0.035*

ISSN: 1532-429X